# Alimentiv: GI CRO \| Gastroenterology Clinical Trials

> Alimentiv: a specialized gastrointestinal CRO delivering full\-service clinical trials spanning clinical study management, central imaging, biomarkers, \& more\.

Generated by Yoast SEO v26.9, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Contact Us](https://alimentiv.com/contact-us/)
- [Statistics](https://alimentiv.com/services/clinical-trial-services/gi-biostatistics-for-clinical-research/)
- [Central Reading](https://alimentiv.com/services/medical-imaging-solutions/central-reading/)
- [Our MR\&D Legacy](https://alimentiv.com/about-us/our-mrd-legacy/)
- [Privacy Notice](https://alimentiv.com/privacy-notice/)

## Events
- [7th SEBRADII 2026](https://alimentiv.com/events/sebradii-202/)
- [European Crohn’s and Colitis Organisation \(ECCO\) 2026](https://alimentiv.com/events/ecco-2026/)
- [Digestive Disease Week® \(DDW\)](https://alimentiv.com/events/ddw/)
- [AOCC 2026](https://www.alimentiv.com/events/aocc-2026/)
- [Precision Medicine in Inflammatory Bowel Disease Summit](https://www.alimentiv.com/events/precision-medicine-in-ibd/)

## News
- [Alimentiv, Summit Clinical Research Announce Collaboration to drive Non\-Alcoholic Steatohepatitis \(NASH\) Clinical Trials](https://alimentiv.com/news/alimentiv-summit-clinical-research-announce-collaboration-to-drive-non-alcoholic-steatohepatitis-nash-clinical-trials/)
- [Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI\-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials](https://alimentiv.com/news/alimentiv-and-satisfai-health-announce-commercial-availability-of-highly-innovative-ai-powered-scoring-tool-for-the-assessment-of-ulcerative-colitis-in-stage-i-through-iv-clinical-trials/)
- [Alimentiv Selects Veeva Vault to Launch eTMF Solution](https://alimentiv.com/news/alimentiv-selects-veeva-vault-to-launch-etmf-solution/): London, ON, CANADA, Release: August 12, 2021 –Alimentiv, Inc\. announced today the launch of their new eTMF solution in partnership with Veeva Vault eTMF, offering sponsors real\-time data and secure access to all clinical documentation throughout the clinical trial lifecycle\. As part of its strategy to modernize its technology landscape, Alimentiv selected Vault eTMF to improve
- [Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials\.](https://alimentiv.com/news/alimentiv-acelabio-and-pharmanest-unite-to-revolutionize-precision-medicine-and-ai-digital-pathology-for-nash-mash-clinical-trials/)
- [Alimentiv Inc\. Announces New Scientific Advisors Leading Research In GI\-Related Therapeutics](https://alimentiv.com/news/alimentiv-inc-announces-new-scientific-advisors-leading-research-in-gi-related-therapeutics/)

## Resource
- [Connecting the Spots: How Histopathology Expertise Supports Spatial Transcriptomics Analysis](https://alimentiv.com/resources/how-histopathology-expertise-supports-spatial-transcriptomics-analysis/)
- [Alimentiv’s Digital Pathology Innovation With Visiopharm®: An Interview With Dr\. Pavine Lefevre](https://alimentiv.com/resources/digital-pathology-innovation-with-visiopharm/)
- [A Practical Look at Sample Size Re\-Estimation of the Promising Zone Design](https://alimentiv.com/resources/a-practical-look-at-sample-size-re-estimation-of-the-promising-zone-design/)
- [End\-to\-End GI Clinical Services \& Solutions](https://www.alimentiv.com/resources/end-to-end-gi-clinical-services-solutions/)
- [CIMS Medical Imaging Endoscopy Solutions](https://alimentiv.com/resources/cims-medical-imaging-endoscopy-solutions/)

## Publications
- [Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta\-Analysis](https://alimentiv.com/publication/placebo-rates-in-crohns-disease-randomized-clinical-trials/)
- [Meta\-Analysis: Evaluating Placebo Rates Across Outcomes in Eosinophilic Oesophagitis Randomised Controlled Trials](https://alimentiv.com/publication/meta-analysis-evaluating-placebo-rates-across-outcomes-in-eosinophilic-oesophagitis-randomised-controlled-trials/)
- [Efficacy and Safety of Advanced Combination Treatment in Immune\-Mediated Inflammatory Disease: A Systematic Review and Meta\-Analysis of Randomized Controlled Trials](https://alimentiv.com/publication/efficacy-and-safety-of-advanced-combination-treatment-in-immune-mediated-inflammatory-disease-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/)
- [Responsiveness of Different Disease Activity Indices in Moderate\-To\-Severe Ulcerative Colitis](https://alimentiv.com/publication/responsiveness-of-different-disease-activity-indices-in-moderate-to-severe-ulcerative-colitis/)
- [Management of Complications in Patients With an Ileostomy: An Umbrella Review of Systematic Reviews for the Endotrial Consortium](https://alimentiv.com/publication/management-of-complications-in-patients-with-an-ileostomy-an-umbrella-review-of-systematic-reviews-for-the-endotrial-consortium/)

## Leadership
- [Nick Powell, M\.D\.](https://alimentiv.com/about-us/our-experts/nick-powell-md/)
- [Pierre Gaudreault](https://alimentiv.com/about-us/our-experts/pierre-gaudreault/)
- [Vipul Jairath](https://alimentiv.com/about-us/our-experts/vipul-jairath/)
- [Mike Reffeitt](https://alimentiv.com/about-us/our-experts/mike-reffeitt/)
- [Clare McNally](https://alimentiv.com/about-us/our-experts/clare-mcnally/)

## Optional
- [Sitemap index](http://alimentiv.com/sitemap_index.xml)